A Study of Abemaciclib in Recurrent Glioblastoma
Clinical trial NCT02981940 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02981940
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-09
- Primary completion
- 2024-06-30
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.